Foamix Pharmaceuticals Ltd. will host a Key Opinion Leader breakfast on Tuesday, November 4, 2014 from 8:00am-9:30am Eastern Time in New York City.

The meeting will feature key opinion leader Mark Lebwohl, MD, who leads a renowned dermatology program in the U.S., as the Sol and Clara Kest Professor and Chairman of Mount Sinai's Department of Dermatology, a position that he has held since 1996. Dr. Lebwohl has been elected President of the American Academy of Dermatology for the 2015-2016 term.

Dr. Lebwohl has also authored or co-authoredmore than 500 publications and written and edited several books, including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease.

Key members of the Foamix executive management team, including Dov Tamarkin, Chief Executive Officer, and Dave Domzalski, President of U.S. Subsidiary Foamix Pharmaceuticals Inc.,will provide a brief overview of the company and will also be available for Q&A.

For more information go to: http://foamixpharma.com.